MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. OKUR
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

OnKure Therapeutics (OKUR) Revenue & Earnings 2021-2026

Revenue, EBITDA, operating income, net income, EPS, and shares

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$0
Q. Revenue
$0
TTM EBITDA
$-61.74M
13.2%
TTM Op. Income
$-62.14M
13.4%
Q. Op. Income
$-16.90M
TTM Net Income
$-58.70M
16.4%
Q. Net Income
$-15.35M
EPS
$-0.31
Shares Out.
$49.87M
269.2%
$0 in TTM revenue was flat at zero YoY, reaching $0 last quarter. TTM EBITDA of $-61.74M and TTM operating income of $-62.14M show growth is flowing through to the bottom line. However, net income is negative at $58.70M — growth is not yet reaching the bottom line.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders